KSF investigates Kyndryl after delayed 10-Q and control weakness warning

The law firm said Kyndryl's Feb. 9, 2026 disclosure flagged expected material weaknesses, alongside the departure of its C.F.O and General Counsel, and was followed by an ongoing securities class action.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.